Metabolites
Displaying metabolites 1576 - 1600 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB24821 | DG(19:0cycv8c/16:0/0:0) | (2R)-3-{[10-(2-hexylcyclopropyl)decanoyl]oxy}-2-hydroxypropyl hexadecanoate | 608.989 C38H72O5 | ||
ECMDB23285 | DG(16:0/19:1(9Z)/0:0) | (2S)-3-(hexadecanoyloxy)-2-hydroxypropyl (9Z)-nonadec-9-enoate | phospholipid biosynthesis (PE(16:0/19:iso)) PW001751 | 608.989 C38H72O5 | |
ECMDB23317 | DG(19:1(9Z)/16:0/0:0) | (2R)-3-(hexadecanoyloxy)-2-hydroxypropyl (9Z)-nonadec-9-enoate | phospholipid biosynthesis (CDP-DG(19:1(9Z)/16:0)) PW001790 | 608.989 C38H72O5 | |
ECMDB23445 | PE(10:0(3-OH)/15:0) | (2-aminoethoxy)[(2R)-3-[(3-hydroxydecanoyl)oxy]-2-(pentadecanoyloxy)propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(10:0/15:0) PW001749 | 609.7725 C30H60NO9P | |
ECMDB23493 | PE(15:0/10:0(3-OH)) | (2-aminoethoxy)[(2R)-2-[(3-hydroxydecanoyl)oxy]-3-(pentadecanoyloxy)propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(15:0/10:0) PW001805 | 609.7725 C30H60NO9P | |
ECMDB21265 | PG(12:0/12:0) | [(2R)-2,3-bis(dodecanoyloxy)propoxy][(2S)-2,3-dihydroxypropoxy]phosphinic acid | phospholipid biosynthesis (CL(12:0(3-OH)/12:0(3-OH)/12:0/12:0)) PW001915 phospholipid biosynthesis (CL(12:0(3-OH)/12:0/12:0/12:0)) PW001917 phospholipid biosynthesis (CL(12:0(3-OH)/17:0cycw7c/12:0/12:0)) PW001923 phospholipid biosynthesis (CL(12:0/12:0(3-OH)/12:0/12:0)) PW001929 More...phospholipid biosynthesis (CL(12:0/12:0/12:0/12:0)) PW001930 phospholipid biosynthesis (CL(12:0/17:0cycw7c/12:0/12:0)) PW001932 phospholipid biosynthesis (CL(16:0/12:0/12:0/12:0)) 2 PW001952 phospholipid biosynthesis (CL(16:1(9Z)/12:0/12:0/12:0)) PW001955 phospholipid biosynthesis (CL(17:0cycw7c/12:0/12:0/12:0)) PW001972 phospholipid biosynthesis (CL(18:0/12:0/12:0/12:0)) PW001975 phospholipid biosynthesis (CL(18:1(11Z)/12:0/12:0/12:0)) PW001977 | 610.766 C30H59O10P | |
ECMDB23537 | PS(10:0(3-OH)/12:0) | (2S)-2-amino-3-({[(2R)-2-(dodecanoyloxy)-3-[(3-hydroxydecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid | 611.71 C28H54NO11P | ||
ECMDB23550 | PS(10:0/12:0(3-OH)) | (2S)-2-amino-3-({[(2R)-3-(decanoyloxy)-2-[(3-hydroxydodecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid | phospholipid biosynthesis CDP-DG(10:0/12:0) IV PW001820 | 611.71 C28H54NO11P | |
ECMDB23553 | PS(12:0(3-OH)/10:0) | (2S)-2-amino-3-({[(2R)-2-(decanoyloxy)-3-[(3-hydroxydodecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid | phospholipid biosynthesis CDP-DG(12:0/10:0) III PW001835 | 611.71 C28H54NO11P | |
ECMDB23567 | PS(12:0/10:0(3-OH)) | (2S)-2-amino-3-({[(2R)-3-(dodecanoyloxy)-2-[(3-hydroxydecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)propanoic acid | phospholipid biosynthesis CDP-DG(12:0/10:0) IV PW001844 | 611.71 C28H54NO11P | |
ECMDB23444 | PE(10:0(3-OH)/14:0(3-OH)) | (2-aminoethoxy)[(2R)-3-[(3-hydroxydecanoyl)oxy]-2-[(3-hydroxytetradecanoyl)oxy]propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(10:0/14:0) PW001747 | 611.7453 C29H58NO10P | |
ECMDB23460 | PE(12:0(3-OH)/12:0(3-OH)) | (2-aminoethoxy)[(2R)-2,3-bis[(3-hydroxydodecanoyl)oxy]propoxy]phosphinic acid | phospholipid biosynthesis (CL(12:0(3-OH)/12:0(3-OH)/12:0/12:0)) PW001915 | 611.7453 C29H58NO10P | |
ECMDB23476 | PE(14:0(3-OH)/10:0(3-OH)) | (2-aminoethoxy)[(2R)-2-[(3-hydroxydecanoyl)oxy]-3-[(3-hydroxytetradecanoyl)oxy]propoxy]phosphinic acid | phospholipid biosynthesis CDP-DG(14:0/10:0) PW001793 | 611.7453 C29H58NO10P | |
ECMDB21221 | Glutathione disulfide 27025-41-8 | 2-amino-4-[(2-{[2-(4-amino-4-carboxybutanamido)-2-[(carboxymethyl)carbamoyl]ethyl]disulfanyl}-1-[(carboxymethyl)carbamoyl]ethyl)carbamoyl]butanoic acid | 612.631 C20H32N6O12S2 | ||
ECMDB21333 | Ferroxamine 14836-73-8 | 613.505 C25H45FeN6O8 | |||
ECMDB21413 | Cytidine monophosphate N-acetylneuraminic acid 22-12-8 | (2R,4S,5R,6R)-2-[({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid | 614.4511 C20H31N4O16P | ||
ECMDB24252 | ferroheme b | 5,9-bis(2-carboxylatoethyl)-14,19-diethenyl-4,10,15,20-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]tetracosa-1,3(24),4,6,8(23),9,11,13,15,17,19-undecaene-21,22-diide iron | TCA cycle PW000779 More...TCA cycle (ubiquinol-10) PW001010 TCA cycle (ubiquinol-2) PW001002 TCA cycle (ubiquinol-3) PW001003 TCA cycle (ubiquinol-4) PW001004 TCA cycle (ubiquinol-5) PW001005 TCA cycle (ubiquinol-6) PW001006 TCA cycle (ubiquinol-7) PW001007 TCA cycle (ubiquinol-8) PW001008 TCA cycle (ubiquinol-9) PW001009 TCA cycle (ubiquinol-0) PW002023 pyruvate to cytochrome bd terminal oxidase electron transfer PW002087 | 614.485 C34H30FeN4O4 | |
ECMDB23634 | PG(10:0(3-OH)/12:0(3-OH)) | [(2S)-2,3-dihydroxypropoxy][(2R)-2-[(3-hydroxydecanoyl)oxy]-3-[(3-hydroxydodecanoyl)oxy]propoxy]phosphinic acid | phospholipid biosynthesis (CL(10:0(3-OH)/12:0(3-OH)/10:0(3-OH)/12:0(3-OH))) PW001900 | 614.71 C28H55O12P | |
ECMDB23650 | PG(12:0(3-OH)/10:0(3-OH)) | [(2S)-2,3-dihydroxypropoxy][(2R)-3-[(3-hydroxydecanoyl)oxy]-2-[(3-hydroxydodecanoyl)oxy]propoxy]phosphinic acid | phospholipid biosynthesis (CL(12:0(3-OH)/10:0(3-OH)/12:0(3-OH)/10:0(3-OH))) PW001913 | 614.71 C28H55O12P | |
ECMDB03178 | Heme 14875-96-8 | 4,20-bis(2-carboxyethyl)-10,15-diethenyl-5,9,14,19-tetramethyl-2lambda5,22,23lambda5,25-tetraaza-1-ferraoctacyclo[11.9.1.1^{1,8}.1^{3,21}.0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-2,4,6,8,10,12,14,16(23),17,19,21(24)-undecaene-2,23-bis(ylium)-1,1-diuide | 616.487 C34H32FeN4O4 | ||
ECMDB21332 | ferroxamine minus Fe(3) | iron(3+) ion 3-[(5-aminopentyl)(hydroxy)carbamoyl]-N-[5-(N-hydroxy-3-{[5-(N-hydroxyacetamido)pentyl]-C-hydroxycarbonimidoyl}propanamido)pentyl]propanimidic acid | 616.529 C25H48FeN6O8 | ||
ECMDB24180 | ADP-L-glycero-beta-D-manno-heptose | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(2S,3S,4S,5S,6R)-6-[(1S)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl phosphonato]oxy}phosphonate | 617.355 C17H25N5O16P2 | ||
ECMDB21294 | UDP-N-Acetyl-D-mannosaminouronate | (2S,3S,4R,5S,6R)-6-({[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-oxido-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3,4-dihydroxy-5-[(1-oxidoethylidene)amino]oxane-2-carboxylate | 618.3134 C17H22N3O18P2 | ||
ECMDB24236 | UDP-N-acetyl-α-D-mannosaminuronate | 6-{[({[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphinato]oxy}-5-acetamido-3,4-dihydroxyoxane-2-carboxylate | Amino sugar and nucleotide sugar metabolism I PW000886 | 618.315 C17H22N3O18P2 | |
ECMDB20112 | ADP-D-Glycero-D-manno-heptose | [({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(3S,4S,5S,6R)-6-[(1R)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl]oxy})phosphinic acid | 619.3677 C17H27N5O16P2 |